Related Experiment Video

Updated: Jan 11, 2026

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
11:03

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Published on: February 10, 2020

7.7K

Plasma TDP-43 is a potential biomarker for advanced limbic-predominant age-related TDP-43 encephalopathy

Jijing Wang1,2,3, Julie A Schneider4,5, David A Bennett4,5

  • 1Department of Neurology, Brigham and Women's Hospital, Boston, MA, 02115, USA.

Molecular Neurodegeneration
|November 13, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.1K
Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

9.1K

Related Experiment Videos

Last Updated: Jan 11, 2026

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
11:03

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Published on: February 10, 2020

7.7K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.1K
Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

9.1K

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

Articles linked to this work by shared authors, journal, and citation graph.

Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease.

Acta neuropathologica·2016

Association of cognitive activity and neurocognitive function in blacks and whites with HIV.

AIDS (London, England)·2016

The characteristics of astrocyte on Aβ clearance altered in Alzheimer's disease were reversed by anti-inflammatory agent (+)-2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate.

American journal of translational research·2016

Novel genetic loci underlying human intracranial volume identified through genome-wide association.

Nature neuroscience·2016

Self-Reported Sleep in Older African Americans and White Americans.

Ethnicity & disease·2016

Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2016

Retromer-targeted therapy for neurodegenerative diseases.

Molecular neurodegeneration·2026

Lipid-driven membrane remodeling engages a lysosome-dependent adaptive repair program during retinal aging.

Molecular neurodegeneration·2026

Advancing a systems-level understanding of neurodegeneration: the BrightFocus Alzheimer's disease research portfolio.

Molecular neurodegeneration·2026

AQP4-dependent enhancement of glymphatic function attenuates tau pathology and neurodegeneration in PS19 mice.

Molecular neurodegeneration·2026

The complex lipidome as a driver of tissue-specific pathology in adrenoleukodystrophy.

Molecular neurodegeneration·2026

Diabetic retinopathy: shaped by the "hidden hand" of post-translational modifications.

Molecular neurodegeneration·2026

Integrated approaches to geriatric mental disorders: pathophysiology, interventions, and precision medicine horizons.

Frontiers in psychiatry·2026

Participatory Approaches with Older Adults in Technology and Innovation Research: A Scoping Review of Reviews.

The Gerontologist·2026

Trauma, personality, and depression among middle-aged and older adults during the COVID-19 pandemic.

Psychological trauma : theory, research, practice and policy·2026

Development of a Lower Limb Digital Twin Model for Analyzing Femoral Injuries in Elderly CPC Subjects.

Biomimetics (Basel, Switzerland)·2026

The "Dark Side" of Pre-Retirement Work Attachment for Later-Life Mental Health: Mediating Role of Retirement Adjustment and Moderating Role of Social Network.

Psychology research and behavior management·2026

Divergent amyloid trajectories distinguish normal aging from Alzheimer's disease progression.

bioRxiv : the preprint server for biology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us